Clinical Trials Directory

Trials / Completed

CompletedNCT03484455

Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant

A Prospective Randomized Multi-Center Study of the Use of the Organ Recovery Systems LifePort® Liver Transporter (LLT) System With Vasosol® as Compared to Static Cold Storage in Orthotopic Liver Transplants (Perfusion to Improve Liver Outcomes in Transplantation)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
142 (actual)
Sponsor
Organ Recovery Systems, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Comparison of hypothermic machine perfusion of livers to standard of care (static cold storage).

Detailed description

Prospective, randomized, multi-center study to show safe and effective use of whole liver preservation via hypothermic machine perfusion (HMP) as compared to livers preserved by static cold storage.

Conditions

Interventions

TypeNameDescription
DEVICEHypothermic machine perfusionOrgan Recovery Systems LifePort® Liver Transporter (LLT) System and Vasosol® Machine Perfusion Solution
DEVICEStatic cold storageStatic cold storage (standard of care)

Timeline

Start date
2019-04-03
Primary completion
2022-07-12
Completion
2022-07-12
First posted
2018-03-30
Last updated
2022-10-07

Locations

9 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03484455. Inclusion in this directory is not an endorsement.